Last10K.com

Melinta Therapeutics, Inc. (MLNTQ) SEC Filing 8-K Material Event for the period ending Friday, February 7, 2020

Foreign Trade Bank Of Latin America, Inc

HISTORY TOOLS
CIK: 1461993 Ticker: BLX

View differences made from one to another to evaluate Foreign Trade Bank Of Latin America, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Foreign Trade Bank Of Latin America, Inc..

Continue

Assess how Foreign Trade Bank Of Latin America, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Foreign Trade Bank Of Latin America, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Foreign Trade Bank Of Latin America, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: BLX
CIK: 890541
Form Type: 8-K Corporate News
Accession Number: 0001193125-20-038710
Submitted to the SEC: Fri Feb 14 2020 7:38:32 PM EST
Accepted by the SEC: Tue Feb 18 2020
Period: Friday, February 7, 2020
Industry: Commercial Banks
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/blx/0001193125-20-038710.htm